ArticleInternational journal of oncology2020

Inhibition of pyruvate dehydrogenase kinase‑1 by dicoumarol enhances the sensitivity of hepatocellular carcinoma cells to oxaliplatin via metabolic reprogramming.

Huadan Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.